BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3343895)

  • 1. GTP effects in rat brain slices support the non-interconvertability of M1 and M2 muscarinic acetylcholine receptors.
    Spencer DG; Horváth E; Traber J; Van Rooijen LA
    Life Sci; 1988; 42(9):993-7. PubMed ID: 3343895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections.
    Spencer DG; Horváth E; Traber J
    Brain Res; 1986 Aug; 380(1):59-68. PubMed ID: 3756473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]oxotremorine-M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors.
    Bevan P
    Eur J Pharmacol; 1984 May; 101(1-2):101-10. PubMed ID: 6547676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P; Ebinger G; Vauquelin G
    Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and quantitative autoradiographic distribution of [3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor sub-type.
    Quirion R; Araujo D; Regenold W; Boksa P
    Neuroscience; 1989; 29(2):271-89. PubMed ID: 2725859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiographic distribution of [3H]AF-DX 116 muscarinic-M2 receptor binding sites in rat brain.
    Regenold W; Araujo DM; Quirion R
    Synapse; 1989; 4(2):115-25. PubMed ID: 2781464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of WEB 1881 FU, a novel nootropic, on cholinergic and adrenergic receptors in the rat brain: action on M1-muscarinic receptors.
    Kitamura Y; Hayashi S; Nomura Y
    Jpn J Pharmacol; 1990 Apr; 52(4):597-607. PubMed ID: 2188026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices.
    Lapchak PA; Araujo DM; Quirion R; Collier B
    Brain Res; 1989 Sep; 496(1-2):285-94. PubMed ID: 2804636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R; Palacios JM
    Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and behavioral evidence for muscarinic autoreceptors in the CNS.
    Hoss W; Messer WS; Monsma FJ; Miller MD; Ellerbrock BR; Scranton T; Ghodsi-Hovsepian S; Price MA; Balan S; Mazloum Z
    Brain Res; 1990 May; 517(1-2):195-201. PubMed ID: 2375989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study.
    Atack JR; Wenk GL; Wagster MV; Kellar KJ; Whitehouse PJ; Rapoport SI
    Brain Res; 1989 Apr; 483(2):367-72. PubMed ID: 2706526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.
    Mash DC; Potter LT
    Neuroscience; 1986 Oct; 19(2):551-64. PubMed ID: 3774154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
    Messer WS; Ellerbrock B; Price M; Hoss W
    Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.